← Back to Search

Efficacy for Lifestyle PA for Self-Efficacy

N/A
Waitlist Available
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline, at week 2, 3, and 4, as well as end of study (beginning of week 8)
Awards & highlights

Summary

The purpose of this study is to evaluate the efficacy of three, brief (10-minute) theory-guided video chats for increasing self-efficacy for lifestyle physical activity versus a time-matched video chat comparison group designed to increase self-efficacy for work-life balance. Participants will include individuals who are low-active, full-time (\>35 hours/week) working adults.

Eligible Conditions
  • Self-Efficacy
  • Physical Activity
  • Working Adults

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, at week 2, 3, and 4, as well as end of study (beginning of week 8)
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline, at week 2, 3, and 4, as well as end of study (beginning of week 8) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Self-efficacy for Lifestyle Physical Activity (SELPA)
Secondary study objectives
Anticipated Negative Affect
Exercise Planning and Scheduling
Exercise Self-Schema
+12 more
Other study objectives
Overall Enjoyment with Physical Activity

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Efficacy for Lifestyle PAExperimental Treatment1 Intervention
Three brief (10-minute) video chats during first three weeks of six weeks of lifestyle physical activity engagement providing information relative to outcome expectations (week 1), self-efficacy (week 2), and self-regulatory strategies (week 3) to enhance self-efficacy for lifestyle physical activity.
Group II: Efficacy for Work-life BalanceActive Control1 Intervention
Three brief (10-minute) video chats during first three weeks of six weeks of lifestyle physical activity engagement providing information relative to outcome expectations (week 1), self-efficacy (week 2), and self-regulatory strategies (week 3) to enhance self-efficacy for work-life balance.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Efficacy for Lifestyle PA
2019
N/A
~80

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
196 Previous Clinical Trials
38,131 Total Patients Enrolled
~11 spots leftby Sep 2025